$EMBC
Embecta Corp. Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
$5.75
▼-2.71%-$0.160
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateEmbecta Corp. Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Why is EMBC down today? It is at $5.75 (-2.71%), and our scanner flagged it 54 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment EMBC spikes, and full due diligence on EMBC — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $EMBC 54 times in the last 30 days. Create a free account to track $EMBC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on EMBC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EMBC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystEmbecta Corp.: Q3 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 8, 2026 · 30 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Morris Milton Mayo Director | Sold (automatic/other) | -6K 0.01% of company | sold 10% | 54K | $37K at $5.88 | Sep 4, 26 |
Hombach Robert J. Director | Bought (open market) | +45K 0.08% of company | added 70% | 110K | $224K at $4.97 | Aug 12, 26 |
Mann Jeffrey Z Officer | Bought (open market) | +20K 0.04% of company | added 8.2% | 263K | $100K at $4.99 | Aug 12, 26 |
Elguicze Jacob Officer | Bought (open market) | +20K 0.04% of company | added 6.9% | 309K | $93K at $4.67 | Aug 12, 26 |
Kurdikar Devdatt Officer | Bought (open market) | +30K 0.05% of company | added 3.9% | 805K | $141K at $4.70 | Aug 12, 26 |
Casner Jean Officer | Sold (automatic/other) | -1K | sold 1.7% | 86K | $7K at $4.42 | Aug 9, 26 |
Roth Anthony M. Officer | Acquired (grant/award) | +30K 0.05% of company | added 61% | 79K | n/a | Jun 1, 26 |
Reidy Christopher R Director | Acquired (grant/award) | +23K 0.04% of company | added 48% | 70K | n/a | Feb 11, 26 |
Pomeroy Claire Director | Acquired (grant/award) | +23K 0.04% of company | added 53% | 66K | n/a | Feb 11, 26 |
Prange Karen Director | Acquired (grant/award) | +23K 0.04% of company | added 55% | 65K | n/a | Feb 11, 26 |
Morris Milton Mayo Director | Acquired (grant/award) | +23K 0.04% of company | added 61% | 60K | n/a | Feb 11, 26 |
Hombach Robert J. Director | Acquired (grant/award) | +23K 0.04% of company | added 55% | 65K | n/a | Feb 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in surgical & medical instruments & apparatus, closest in size first.
Here is the latest on EMBC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EMBC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
EMBC last traded at $5.75, down 2.71% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Embecta Corp. Common Stock (EMBC) is next expected to report earnings on Tuesday, November 24, 2026, about 47 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. EMBC currently has a dividend yield of about 0.68% ($0.04 per share per year). Dividend figures can change; this is not investment advice.
The EMBC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged EMBC 54 times in the last 30 days.
EMBC (Embecta Corp. Common Stock) trades on XNAS, with a market cap of about $326M in the Surgical & Medical Instruments & Apparatus sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge EMBC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$EMBC discussion
Sign in to ask a question or join the discussion.